American Assets Investment Management’s United Therapeutics UTHR Stock Holding History

American Assets Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.42M	Hold	10,000	–	–	0.33%	75
2026 Q1	$5.93M	Hold	10,000	–	–	0.4%	69
2025 Q4	$4.87M	Hold	10,000	–	–	0.34%	78
2025 Q3	$4.19M	Hold	10,000	–	–	0.31%	84
2025 Q2	$2.87M	Hold	10,000	–	–	0.23%	98
2025 Q1	$3.08M	Hold	10,000	–	–	0.27%	98
2024 Q4	$3.53M	Hold	10,000	–	–	0.29%	89
2024 Q3	$3.58M	Hold	10,000	–	–	0.31%	96
2024 Q2	$3.19M	Hold	10,000	–	–	0.3%	94
2024 Q1	$2.3M	Hold	10,000	–	–	0.22%	108
2023 Q4	$2.2M	Hold	10,000	–	–	0.23%	110
2023 Q3	$2.26M	Hold	10,000	–	–	0.25%	102
2023 Q2	$2.21M	Hold	10,000	–	–	0.25%	108
2023 Q1	$2.24M	Hold	10,000	–	–	0.26%	105
2022 Q4	$2.78M	Hold	10,000	–	–	0.32%	89
2022 Q3	$2.09M	Hold	10,000	–	–	0.27%	95
2022 Q2	$2.36M	Hold	10,000	–	–	0.29%	91
2022 Q1	$1.79M	Hold	10,000	–	–	0.19%	118
2021 Q4	$2.16M	Hold	10,000	–	–	0.23%	103
2021 Q3	$1.85M	Hold	10,000	–	–	0.23%	106
2021 Q2	$1.79M	Hold	10,000	–	–	0.23%	105
2021 Q1	$1.67M	Hold	10,000	–	–	0.23%	101
2020 Q4	$1.52M	Buy	+10,000	New	+$1.31M	0.25%	98

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

American Assets Investment Management's UTHR Position: Q2 2026 in Review

American Assets Investment Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 10,000 shares worth $5.42M. The position accounts for 0.33% of the portfolio, ranked #75.

American Assets Investment Management first reported a position in UTHR in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.93M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

American Assets Investment Management held 10,000 shares of United Therapeutics worth $5.42M as of Q2 2026.
American Assets Investment Management left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up 0.33% of American Assets Investment Management's portfolio in Q2 2026, its #75 holding.
American Assets Investment Management first reported a position in United Therapeutics in Q4 2020 and has held it in 23 quarters since.
American Assets Investment Management's United Therapeutics position peaked at $5.93M in Q1 2026.
884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on American Assets Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.